Company Myovant Sciences Ltd.
Equities
MYOV
BMG637AM1024
Biotechnology & Medical Research
Business Summary
Number of employees: 579
Managers
Managers | Title | Age | Since |
---|---|---|---|
David C. Marek
CEO | Chief Executive Officer | 59 | 21-01-03 |
Adele Gulfo
BRD | Director/Board Member | 61 | 19-12-26 |
Marianne Romeo
PRN | Corporate Officer/Principal | 56 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 19-12-26 |
David C. Marek
CEO | Chief Executive Officer | 59 | 21-01-03 |
Director/Board Member | 59 | 22-10-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 97,235,316 | 46,097,791 ( 47.41 %) | 0 | 47.41 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+51.89% | 55.7B | |
+40.74% | 39.91B | |
-6.03% | 39.57B | |
-5.56% | 28.16B | |
+15.79% | 26.3B | |
-20.27% | 18.94B | |
+31.48% | 12.17B | |
+26.33% | 12.12B | |
+1.16% | 12.12B |